ArticleNeurology2026
The Prognostic Value of Paramagnetic Rim Lesions in People With Multiple Sclerosis.
Article in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesParamagnetic rim lesions (PRLs) have been established as a radiologic surrogate for chronic active inflammation in multiple sclerosis (MS). Although associations between PRLs and disability have been observed, data on their prognostic value for long-term risk of clinical worsening, especially in the form of progression independent of relapse activity (PIRA), remain limited. In this study, we assessed the association of PRLs with future disability accumulation over a median follow-up of 5 years and their relation to other (para) clinical parameters.
methodsFrom a large, ongoing single-center cohort study, people with MS were included according to the availability of susceptibility-sensitive MRI. PRLs were segmented on reconstructed quantitative susceptibility mapping scans using a deep learning-based segmentation model, visually inspected for plausibility, and corrected if necessary. Multivariable Cox proportional hazards models were used to investigate the prognostic value of PRLs for disability outcomes, including confirmed disability accumulation (CDA) and PIRA. Sensitivity analyses based on PRL count, MS diagnosis, prior disability accumulation, and treatment during follow-up were performed to evaluate the robustness of our findings. In addition, associations between PRL status and CSF parameters as well as future brain atrophy, measured by annual percentage brain volume change, were assessed in an exploratory manner.
resultsAmong 862 participants (mean age 40.3 years, 64.7% female), 395 (45.8%) had at least 1 PRL. Over a median follow-up of 5.1 years, 142 of 801 individuals with clinical follow-up for longitudinal analysis experienced CDA (17.7%), and 104 of these CDA events (73.2%) occurred as PIRA. The presence of PRLs was associated with a higher risk of PIRA (adjusted hazard ratio 1.8, 95% CI 1.1-2.8; DISCUSSION: PRLs are associated with an increased risk of future PIRA and accelerated rates of brain atrophy. These findings emphasize their potential as a prognostic biomarker for risk stratification in MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.